Redmile Group

company

About

Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.

  • 11 - 50

Details

Industries
Health Care,Hedge Funds,Venture Capital
Founded date
Jan 1, 2007
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Hedge Fund,PE,Venture Capital

Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.

Investments

Number of Investments
Number of Lead Investments
25
7
Redmile Group has made 25 investments. Their most recent investment was on May 25, 2022, when Rapt Therapeutics raised $50M.
Date Company Name
Round Money Raised Industry Lead Investor
May 25, 2022 Rapt Therapeutics
Post-IPO Equity $50M Biotechnology Yes
Feb 16, 2022 Star Therapeutics
Series Unknown $100M
Oct 7, 2021 Science 37
Post-IPO Equity $200M Biotechnology
Series D $150M Biotechnology Yes
Jul 13, 2021 Prime Medicine
Series B $200M Biotechnology